title: [CD5-positive cardiac intravascular diffuse large-B cell lymphoma: report of a case].
authors: Rong-quan
authors: RQ
authors: He
authors: Gang
authors: G
authors: Chen
authors: E-mail: lizuyun8877@aliyun.com.
authors: Zu-yun
authors: ZY
authors: Li
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D018951:Antigens, CD20 / Q000378:metabolism; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018956:CD5 Antigens / Q000378:metabolism*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005500:Follow-Up Studies; D006338:Heart Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D006352:Heart Ventricles; D006801:Humans; D050835:Interferon Regulatory Factors / Q000378:metabolism; D017493:Leukocyte Common Antigens / Q000378:metabolism; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D051757:PAX5 Transcription Factor / Q000378:metabolism; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab; D014750:Vincristine / Q000627:therapeutic use; D000099218:Interferon Regulatory Factor-4
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D018956:CD5 Antigens; D003520:Cyclophosphamide; D004317:Doxorubicin; D050835:Interferon Regulatory Factors; D017493:Leukocyte Common Antigens; D051757:PAX5 Transcription Factor; D011241:Prednisone; D000069283:Rituximab; D014750:Vincristine; D000099218:Interferon Regulatory Factor-4; C497281:PAX5 protein, human; C571759:R-CHOP protocol